Innate Pharma SA (IPHA)
1.90
-0.01
(-0.52%)
USD |
NASDAQ |
Sep 18, 16:00
1.89
-0.01
(-0.53%)
After-Hours: 20:00
Innate Pharma Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 518.01M |
| Cellectis SA | 91.50M |
| Genfit SA | -- |
| Inventiva SA | 679.05M |
Enterprise Value Related Metrics
| Earnings Yield | -31.07% |
| Normalized Earnings Yield | -31.25 |